Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Bacterial flagellins are potent inducers of innate immune responses in the mouse lung because they bind to TLR5 expressed on the apical surfaces of airway epithelial cells. TLR engagement leads to the initiation of a signaling cascade that results in a pro-inflammatory response with subsequent up-regulation of several cytokines and leads to adaptive immune responses. We examined the ability of two soluble flagellins, a monomeric flagellin expressed in E. coli and a highly purified polymeric flagellin directly isolated from Salmonella, to enhance the efficacy of influenza vaccines in mice. Here we demonstrate that both flagellins co-administered intranasally with inactivated A/PR/8/34 (PR8) virus induced robust increases of systemic influenza-specific IgA and IgG titers and resulted in a more comprehensive humoral response as indicated by the increase of IgG2a and IgG2b subclass responses. Groups immunized with the adjuvanted vaccines were fully protected against high dose lethal challenge by homologous virus whereas inactivated PR8 alone conferred only partial protection. Finally we show that shortly after immunization the adjuvanted vaccines induced a dramatic increase in pro-inflammatory cytokines in the lung, resulting in extensive lung infiltration by granulocytes and monocytes/macrophages. Our results reveal a promising perspective for the use of both soluble monomeric and polymeric flagellin as mucosal vaccine adjuvants to improve protection against influenza epidemics as well as a range of other infectious diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777 · cited 2×
“In recent years, the study of the mechanisms which regulate the innate immune system has revealed a new group of receptors which are found on the surfaces of antigen presenting cells (APC) [6] and belong to the Toll-like receptor family (TLR) [4,5].”
BackgroundMortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Cited by
Kim, E., Erdos, G., Huang, S., Kenniston, T. W., Balmert, S. C., Carey, C. D., Raj, V. S., Epperly, M. W., Klimstra, W. B., Haagmans, B. L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102743 · Cited by 404
Bacterial flagellin—a potent immunomodulatory agent
Hajam, I. A., Dar, P. A., Shahnawaz, I., Jaume, J. C., & Lee, J. H. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.172 · Cited by 387
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Facciolà, A., Visalli, G., Laganà, A., & Di Pietro, A. (2022) · Vaccines · doi:10.3390/vaccines10050819 · Cited by 316
Dysregulation of human Toll-like receptor function in aging
Shaw, A. C., Panda, A., Joshi, S. R., Qian, F., Allore, H. G., & Montgomery, R. R. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.007 · Cited by 215
“in clinical trials employ the TLR5 agonist flagellin, including vaccines that incorporate highly conserved motifs that offer promise as universal influenza vaccines that would not require yearly reformulation and administration (Adar et al., 2009; Huleatt et al., 2008; Skountzou et al., 2010).”
Age‐associated elevation in TLR5 leads to increased inflammatory responses in the elderly
Qian, F., Wang, X., Zhang, L., Chen, S., Piecychna, M., Allore, H., Bockenstedt, L., Malawista, S., Bucala, R., Shaw, A. C., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00759.x · Cited by 154
“clinical trials employ bacterial flagellin, which is an agonist for TLR5 (Bates et al., 2008; Huleatt et al., 2008; Skountzou et al., 2009; Taylor et al., 2011).”
Background
Metadata
- Authors
- Skountzou, I., Martin, M. D. P., Wang, B., Ye, L., Koutsonanos, D., Weldon, W., Jacob, J., & Compans, R. W.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 28
- Issue
- 24
- Pages
- 4103-4112
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2006246742
- Cited by
- 121
- References
- 2
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. https://app.cochat.ai/papers/10.1016/j.vaccine.2009.07.058
- The paper
- Skountzou, I., Martin, M. D. P., Wang, B., Ye, L., Koutsonanos, D., Weldon, W., Jacob, J., & Compans, R. W. (2010). Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. Vaccine. https://doi.org/10.1016/j.vaccine.2009.07.058
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.